Dr Kundu's outstanding contributions have resulted in the molecular dissection of the regulation of metastatic potential of melanoma and breast cancers by a chemokine like, extra-cellular matrix protein - osteopontin. He has further demonstrated the existence of a novel signaling pathway that involves protein tyrosine kinase in regulating the motility of breast cancer cells.